Skip to main content
OpenTrials
Completed

NCT Number: NCT05348850

Quadriceps Muscle Contractile Properties and Functional Performance

The aim of this study is to investigate the association between tensiomyography parameters (from rectus femoris, vastus lateralis and vastus medialis) and functional abilities in runners with patellofemoral pain syndrome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Haven Health care

El-Sheikh Zayed City, Egypt

About this study

Running is one of the most widespread activities during which overuse injuries of the lower extremity occur. Long-distance running is very popular among participants of recreational sports . In 2008, about 11.5% of the population in the United States ran and, of this group, 3.4% ran on average two times a week or more. In Europe, it is estimated that 36% of the population aged 15-65 years are recreational runners.

Most running-related injuries occur in the lower extremities. The most common anatomical site of running injuries is the knee.

Risk factors for running injuries have been well investigated , However, because of the heterogeneity of the studies (e.g., definition of injury, recreational or elite runners, and short- or long-distance runners), no clear overview is available regarding the most important risk factors for running injuries. Increased training volume per week in male runners, and a history of previous injuries for runners, are known significant risk factors for running injuries.

The various purported risk factors for running injuries are commonly divided into intrinsic and extrinsic risk factors. Intrinsic risk factors include mostly anatomic and other variables that are innate to the individual, such as gender, age, height, weight, personality type (e.g., aggressive, passive), and anatomic factors such as femoral anteversion, genu varus or valgus, pes planus or cavus, bone density, muscular flexibility, and leg-length discrepancies. Extrinsic risk factors include training variables such as mileage, hill running, pace, interval training, equipment (shoes, shoe inserts), and training surfaces.

Patellofemoral pain syndrome is the most common overuse injury of the lower extremity, and is particularly prevalent in those who are physically active. For example, approximately 2.5 million runners will be diagnosed with PFPS in a given year. PFPS also is a significant problem in the military as it has been reported that 37% of recruits develop PFPS while in basic combat training. Females are reported to be at greater risks for PFPS than their male counterparts. Alarmingly, 70% to 90% of individuals with PFPS have recurrent or chronic pain, In addition, the result of a recent study suggest that having PFPS as a younger individual may predispose one to develop patellofemoral osteoarthritis later in life.

One of the most common risk factors of patellofemoral pain syndrome is the imbalance of the quadriceps musculature and maltracking of the patella are 2 potential factors that may lead to PFP.

The nature of PFP is multifactorial, and many risk factors have been associated with this condition. This come in agreement with several authors who reported that patellofemoral pain syndrome is one of the most common injuries in runners.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The athletes age range between 18-30 years old will participate in this study.
  • Both males and females will participate in this study.
  • All athletes will be selected from long-distance runners.
  • All athletes have an average running period (6 days per week and 5 hours per day).

Exclusion criteria

  • Athletes with foot deformities such as hallux valgus, foot supination, pes planus, and pes cavus,
  • Athletes with biomechanical abnormalities and complications affecting walking ability and performance.
  • History of lower limbs or back surgery or injury.
  • Structural or functional leg length discrepancy.

Treatment and study plan

Tensiomayography (TMG)

Device

Quadriceps muscle contractile properties will be assessed using tensiomayography

Primary outcomes

  1. Contractile properties of Quadriceps muscle for 30 runners with patellofemoral pain syndrome

    Time frame: measured at the baseline as it is a cross sectional study

    Will be assessed using Tensiomayography

  2. Anteromedial lunge Functional Performance Test designed for 30 runners with patellofemoral pain syndrome

    Time frame: measured at the baseline as it is a cross sectional study

    Anteromedial lunge test will be performed by each athlete for 3 trails with a 3 min recovery period between .

  3. Step-down Functional Performance Test designed for 30 runners with patellofemoral pain syndrome

    Time frame: measured at the baseline as it is a cross sectional study

    Step-down test will be performed by each athlete for 3 trails with a 3 min recovery

  4. Balance and reach Functional Performance Test designed for 30 runners with patellofemoral pain syndrome

    Time frame: measured at the baseline as it is a cross sectional study

    Balance and reach test will be performed by each athlete for 3 trails with a 3 min recovery

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Correlation Between Contractile Properties of Quadriceps Muscle and Functional Performance in Runners With Patellofemoral Pain Syndrome

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Apr 27, 2022
Registry last updated
Jan 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.